evipedia.ai
← Back

Oxiracetam for Health & Longevity

Created on 10/31/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Oxiracetam, a synthetic memory drug from the 1970s, is sold online to sharpen thinking and is used in Chinese hospitals after brain injury. For health-focused adults, the evidence is weak and mixed: older dementia trials reported better test scores, but the largest oral trial found no benefit, and no study has looked at aging. Short-term side effects were mostly mild; reduced kidney function raises blood levels; online products risk mislabeling. (Full Review)

Protocol

Trial dose (oral)
800 mg twice daily
1,600 mg/day, the regimen in most placebo-controlled trials
Time of day
Morning and early afternoon
Mirrors a study's 8 a.m. and 2 p.m. schedule; limits evening stimulation
Baseline biomarkers
Kidney function sets exposure
Dose reduction with lower eGFR is common practice
Time to effect
Dementia trials
About 12 weeks
Point at which trials judged effects
Induced memory impairment
Within hours
Acute effects in healthy volunteers
Global improvement
Within 1 week
Reported in one trial

Benefits

Contraindications
  • Severe kidney impairment
  • Pregnancy and breastfeeding
  • Hypersensitivity to oxiracetam
    •
Key Interactions
  • Antiepileptic drugs (carbamazepine, valproic acid): lower oxiracetam exposure
  • Benzodiazepines (diazepam): possible partial offset of benzodiazepine effects
  • Anticholinergic drugs (scopolamine): each may blunt the other
  • Food: delayed peak levels of (S)-oxiracetam
    •
Theoretical (inferred from mechanism)
  • Cholinesterase inhibitors (donepezil, rivastigmine): possible nausea or headache
  • Other racetams (piracetam, aniracetam): overstimulation or insomnia
  • Stimulants (caffeine, modafinil): insomnia or nervousness
  • NSAIDs (ibuprofen, naproxen), regular use: higher oxiracetam levels
  • Over-the-counter anticholinergic antihistamines (diphenhydramine, doxylamine): blunted oxiracetam effect, next-day sedation
  • Cholinergic supplements (alpha-GPC, citicoline): possible headache or gastrointestinal upset
    •

Risk & Side Effects

  • High: [risks_high]
    •
  • Medium: [risks_medium]
    •
  • Low: Mild gastrointestinal, skin & general adverse events; overstimulation, insomnia & other nervous-system reactions; allergic-type, liver, kidney, heart-rhythm & respiratory reactions
    •
  • Speculative: Accumulation with reduced kidney function; effects on pregnancy
    •

Monitoring

Marker Target Why
Serum creatinine Men 0.74–1.35 mg/dL; women 0.59–1.04 mg/dL Kidney clearance sets exposure
eGFR No established target; track change from own baseline Falling values lengthen half-life
Cognitive test score (MoCA or computerized battery) No established target; track change from own baseline The outcome oxiracetam aims to improve

Cadence: Baseline before the first dose; cognitive testing at 4 and 12 weeks, then every 6 months if use continues; creatinine and eGFR at 12 weeks, then every 6–12 months, sooner after 65 or with regular NSAID use

Qualitative Assessment

  • Mental clarity and verbal fluency in daily tasks
  • Attention span during demanding work
  • Sleep onset and quality
  • Nervousness, headache or gastrointestinal upset
  • Energy and motivation
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.